Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1962 1
1964 2
1966 1
1969 2
1970 1
1971 2
1972 1
1973 5
1974 10
1975 10
1976 12
1977 9
1978 12
1979 16
1980 23
1981 21
1982 18
1983 16
1984 19
1985 15
1986 27
1987 25
1988 22
1989 20
1990 38
1991 34
1992 24
1993 44
1994 54
1995 57
1996 59
1997 54
1998 57
1999 73
2000 82
2001 87
2002 93
2003 103
2004 126
2005 131
2006 174
2007 170
2008 189
2009 212
2010 192
2011 253
2012 259
2013 308
2014 343
2015 370
2016 410
2017 383
2018 388
2019 441
2020 495
2021 559
2022 499
2023 508
2024 208

Text availability

Article attribute

Article type

Publication date

Search Results

6,871 results

Results by year

Filters applied: . Clear all
Page 1
Endometrial cancer.
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Amant F, et al. Lancet. 2005 Aug 6-12;366(9484):491-505. doi: 10.1016/S0140-6736(05)67063-8. Lancet. 2005. PMID: 16084259 Free article. Review.
Each year, endometrial cancer develops in about 142,000 women worldwide, and an estimated 42,000 women die from this cancer. The typical age-incidence curve for endometrial cancer shows that most cases are diagnosed after the menopause, with the highes …
Each year, endometrial cancer develops in about 142,000 women worldwide, and an estimated 42,000 women die from this cancer. T …
Diagnosis and Management of Endometrial Cancer.
Braun MM, Overbeek-Wager EA, Grumbo RJ. Braun MM, et al. Am Fam Physician. 2016 Mar 15;93(6):468-74. Am Fam Physician. 2016. PMID: 26977831 Free article. Review.
Endometrial cancer is the most common gynecologic malignancy. It is the fourth most common cancer in women in the United States after breast, lung, and colorectal cancers. ...Controlling risk factors such as obesity, diabetes, and hypertension could play a role in t …
Endometrial cancer is the most common gynecologic malignancy. It is the fourth most common cancer in women in the United State …
Endometrial Cancer: An Overview of Pathophysiology, Management, and Care.
Passarello K, Kurian S, Villanueva V. Passarello K, et al. Semin Oncol Nurs. 2019 Apr;35(2):157-165. doi: 10.1016/j.soncn.2019.02.002. Epub 2019 Mar 11. Semin Oncol Nurs. 2019. PMID: 30867105 Review.
OBJECTIVE: To provide an overview of the etiology, diagnosis, treatment, and survivorship concerns surrounding endometrial cancer. DATA SOURCES: A review of articles dated 2006-2018 from PubMed and NCCN guidelines. CONCLUSION: Endometrial cancer is the …
OBJECTIVE: To provide an overview of the etiology, diagnosis, treatment, and survivorship concerns surrounding endometrial cancer …
Endometrial Cancer: Genetic, Metabolic Characteristics, Therapeutic Strategies and Nanomedicine.
Cai Y, Wang B, Xu W, Liu K, Gao Y, Guo C, Chen J, Kamal MA, Yuan C. Cai Y, et al. Curr Med Chem. 2021;28(42):8755-8781. doi: 10.2174/0929867328666210705144456. Curr Med Chem. 2021. PMID: 34225603 Review.
BACKGROUND: Endometrial cancer is the fourth most common malignancy in female population worldwide. ...Nanomedicine in endometrial cancer is poorly studied but the current researches showed great results in treating endometrial cancer. .. …
BACKGROUND: Endometrial cancer is the fourth most common malignancy in female population worldwide. ...Nanomedicine in endo …
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations.
Hamilton CA, Pothuri B, Arend RC, Backes FJ, Gehrig PA, Soliman PT, Thompson JS, Urban RR, Burke WM. Hamilton CA, et al. Gynecol Oncol. 2021 Mar;160(3):817-826. doi: 10.1016/j.ygyno.2020.12.021. Epub 2021 Jan 27. Gynecol Oncol. 2021. PMID: 33516529 Review.
INTRODUCTION: In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical manag …
INTRODUCTION: In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment …
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.
Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Clarke MA, et al. JAMA Intern Med. 2018 Sep 1;178(9):1210-1222. doi: 10.1001/jamainternmed.2018.2820. JAMA Intern Med. 2018. PMID: 30083701 Free PMC article.
STUDY SELECTION: Observational studies reporting the prevalence of PMB in women with endometrial cancer and the risk of endometrial cancer in women with PMB in unselected populations were selected. ...MAIN OUTCOMES AND MEASURES: The pooled prevalence o …
STUDY SELECTION: Observational studies reporting the prevalence of PMB in women with endometrial cancer and the risk of end …
Conservative treatment in early stage endometrial cancer: a review.
Trojano G, Olivieri C, Tinelli R, Damiani GR, Pellegrino A, Cicinelli E. Trojano G, et al. Acta Biomed. 2019 Dec 23;90(4):405-410. doi: 10.23750/abm.v90i4.7800. Acta Biomed. 2019. PMID: 31910163 Free PMC article. Review.
Endometrial Cancer (EC) is the commonest gynecological cancer and its incidence is increasing. ...We reviewed the published literature to clarify in fertile women who have not yet fulfilled their desire for motherhood, what are the strategies, the risks of a conserv …
Endometrial Cancer (EC) is the commonest gynecological cancer and its incidence is increasing. ...We reviewed the published li …
The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.
Sobstyl M, Brecht P, Sobstyl A, Mertowska P, Grywalska E. Sobstyl M, et al. Int J Mol Sci. 2022 May 20;23(10):5756. doi: 10.3390/ijms23105756. Int J Mol Sci. 2022. PMID: 35628566 Free PMC article. Review.
New information displays that gynecological and gastrointestinal tract dysbiosis (disruption of the microbiota homeostasis) can play an active role in the advancement and metastasis of gynecological neoplasms, such as cervical, endometrial, and ovarian cancers. Understanding the …
New information displays that gynecological and gastrointestinal tract dysbiosis (disruption of the microbiota homeostasis) can play an acti …
Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
Fremond S, Andani S, Barkey Wolf J, Dijkstra J, Melsbach S, Jobsen JJ, Brinkhuis M, Roothaan S, Jurgenliemk-Schulz I, Lutgens LCHW, Nout RA, van der Steen-Banasik EM, de Boer SM, Powell ME, Singh N, Mileshkin LR, Mackay HJ, Leary A, Nijman HW, Smit VTHBM, Creutzberg CL, Horeweg N, Koelzer VH, Bosse T. Fremond S, et al. Lancet Digit Health. 2023 Feb;5(2):e71-e82. doi: 10.1016/S2589-7500(22)00210-2. Epub 2022 Dec 7. Lancet Digit Health. 2023. PMID: 36496303 Free article. Clinical Trial.
The ten patients with aggressive p53abn endometrial cancer that was predicted as MMRd showed inflammatory morphology and appeared to have a better prognosis than patients with correctly predicted p53abn endometrial cancer (p=0.30). ...Patients with MMR …
The ten patients with aggressive p53abn endometrial cancer that was predicted as MMRd showed inflammatory morphology and appea …
Molecular testing for endometrial cancer: An SGO clinical practice statement.
Walsh CS, Hacker KE, Secord AA, DeLair DF, McCourt C, Urban R. Walsh CS, et al. Gynecol Oncol. 2023 Jan;168:48-55. doi: 10.1016/j.ygyno.2022.10.024. Epub 2022 Nov 15. Gynecol Oncol. 2023. PMID: 36399812
The Cancer Genome Atlas publication first described the genomic landscape of endometrial cancer and characterized these cancers into four molecular subtypes with different prognoses. ...The goal of this practice statement is to guide appropriate testing, interpretat …
The Cancer Genome Atlas publication first described the genomic landscape of endometrial cancer and characterized these cancer …
6,871 results